Atheroprotective	O
effects	O
of	O
pure	O
tocotrienol	B:C0949647
supplementation	O
in	O
the	O
treatment	O
of	O
rabbits	O
with	O
experimentally	O
induced	O
early	O
and	O
established	O
atherosclerosis	O
.	O

Atheroprotective	O
effects	O
of	O
pure	O
tocotrienol	O
supplementation	B:C0087111
in	O
the	O
treatment	O
of	O
rabbits	O
with	O
experimentally	O
induced	O
early	O
and	O
established	O
atherosclerosis	O
.	O

Atheroprotective	O
effects	O
of	O
pure	O
tocotrienol	O
supplementation	O
in	O
the	O
treatment	B:C0087111
of	O
rabbits	O
with	O
experimentally	O
induced	O
early	O
and	O
established	O
atherosclerosis	O
.	O

Atheroprotective	O
effects	O
of	O
pure	O
tocotrienol	O
supplementation	O
in	O
the	O
treatment	O
of	O
rabbits	B:C0324547
with	O
experimentally	O
induced	O
early	O
and	O
established	O
atherosclerosis	O
.	O

Atheroprotective	O
effects	O
of	O
pure	O
tocotrienol	O
supplementation	O
in	O
the	O
treatment	O
of	O
rabbits	O
with	O
experimentally	O
induced	O
early	O
and	O
established	O
atherosclerosis	B:C0004153
.	O

Atherosclerosis	B:C0004153
is	O
the	O
main	O
cause	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
-	O
related	O
deaths	O
worldwide	O
.	O

Atherosclerosis	O
is	O
the	O
main	O
cause	O
of	O
coronary	B:C0010068
artery	I:C0010068
disease	I:C0010068
-	O
related	O
deaths	O
worldwide	O
.	O

Atherosclerosis	O
is	O
the	O
main	O
cause	O
of	O
coronary	O
artery	I:C0010068
disease	I:C0010068
-	O
related	O
deaths	B:C1306577
worldwide	O
.	O

The	O
atheroprotective	O
properties	O
of	O
pure	O
tocotrienols	B:C0949647
(	O
T3	O
)	O
in	O
the	O
absence	O
of	O
alpha	O
-	I:C0969677
tocopherol	I:C0969677
(	O
α	O
-	I:C0969677
TCP	I:C0969677
)	O
in	O
vitamin	O
E	I:C0042874
has	O
not	O
been	O
extensively	O
examined	O
.	O

The	O
atheroprotective	O
properties	O
of	O
pure	O
tocotrienols	O
(	O
T3	B:C0949647
)	O
in	O
the	O
absence	O
of	O
alpha	O
-	I:C0969677
tocopherol	I:C0969677
(	O
α	O
-	I:C0969677
TCP	I:C0969677
)	O
in	O
vitamin	O
E	I:C0042874
has	O
not	O
been	O
extensively	O
examined	O
.	O

The	O
atheroprotective	O
properties	O
of	O
pure	O
tocotrienols	O
(	O
T3	O
)	O
in	O
the	O
absence	O
of	O
alpha	B:C0969677
-	I:C0969677
tocopherol	I:C0969677
(	O
α	O
-	I:C0969677
TCP	I:C0969677
)	O
in	O
vitamin	O
E	I:C0042874
has	O
not	O
been	O
extensively	O
examined	O
.	O

The	O
atheroprotective	O
properties	O
of	O
pure	O
tocotrienols	O
(	O
T3	O
)	O
in	O
the	O
absence	O
of	O
alpha	O
-	I:C0969677
tocopherol	I:C0969677
(	O
α	B:C0969677
-	I:C0969677
TCP	I:C0969677
)	O
in	O
vitamin	O
E	I:C0042874
has	O
not	O
been	O
extensively	O
examined	O
.	O

The	O
atheroprotective	O
properties	O
of	O
pure	O
tocotrienols	O
(	O
T3	O
)	O
in	O
the	O
absence	O
of	O
alpha	O
-	I:C0969677
tocopherol	I:C0969677
(	O
α	O
-	I:C0969677
TCP	I:C0969677
)	O
in	O
vitamin	B:C0042874
E	I:C0042874
has	O
not	O
been	O
extensively	O
examined	O
.	O

To	O
determine	O
the	O
atheroprotective	O
properties	O
of	O
T3	B:C0949647
in	O
early	O
and	O
established	O
atherosclerosis	O
rabbits	O
.	O

To	O
determine	O
the	O
atheroprotective	O
properties	O
of	O
T3	O
in	O
early	O
and	O
established	O
atherosclerosis	B:C0004153
rabbits	O
.	O

To	O
determine	O
the	O
atheroprotective	O
properties	O
of	O
T3	O
in	O
early	O
and	O
established	O
atherosclerosis	O
rabbits	B:C0324547
.	O

Thirty	O
New	B:C0324547
Zealand	I:C0324547
white	I:C0324547
rabbits	I:C0324547
were	O
divided	O
into	O
two	O
groups	O
,	O
B1	O
and	O
B2	O
which	O
represent	O
early	O
[	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
(	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
)	O
for	O
2	O
weeks	O
]	O
and	O
established	O
(	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
for	O
8	O
weeks	O
)	O
atherosclerosis	O
.	O

Thirty	O
New	O
Zealand	I:C0324547
white	I:C0324547
rabbits	I:C0324547
were	O
divided	O
into	O
two	O
groups	O
,	O
B1	O
and	O
B2	O
which	O
represent	O
early	O
[	O
fed	O
1	O
%	O
high	B:C0012155
cholesterol	I:C0012155
diet	I:C0012155
(	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
)	O
for	O
2	O
weeks	O
]	O
and	O
established	O
(	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
for	O
8	O
weeks	O
)	O
atherosclerosis	O
.	O

Thirty	O
New	O
Zealand	I:C0324547
white	I:C0324547
rabbits	I:C0324547
were	O
divided	O
into	O
two	O
groups	O
,	O
B1	O
and	O
B2	O
which	O
represent	O
early	O
[	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
(	O
high	B:C0012155
cholesterol	I:C0012155
diet	I:C0012155
)	O
for	O
2	O
weeks	O
]	O
and	O
established	O
(	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
for	O
8	O
weeks	O
)	O
atherosclerosis	O
.	O

Thirty	O
New	O
Zealand	I:C0324547
white	I:C0324547
rabbits	I:C0324547
were	O
divided	O
into	O
two	O
groups	O
,	O
B1	O
and	O
B2	O
which	O
represent	O
early	O
[	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
(	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
)	O
for	O
2	O
weeks	O
]	O
and	O
established	O
(	O
fed	O
1	O
%	O
high	B:C0012155
cholesterol	I:C0012155
diet	I:C0012155
for	O
8	O
weeks	O
)	O
atherosclerosis	O
.	O

Thirty	O
New	O
Zealand	I:C0324547
white	I:C0324547
rabbits	I:C0324547
were	O
divided	O
into	O
two	O
groups	O
,	O
B1	O
and	O
B2	O
which	O
represent	O
early	O
[	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
(	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
)	O
for	O
2	O
weeks	O
]	O
and	O
established	O
(	O
fed	O
1	O
%	O
high	O
cholesterol	I:C0012155
diet	I:C0012155
for	O
8	O
weeks	O
)	O
atherosclerosis	B:C0004153
.	O

Each	O
group	O
was	O
subdivided	O
into	O
three	O
intervention	O
arms	O
:	O
1	O
)	O
T3	B:C0949647
-	O
4	O
mg/kg	O
,	O
2	O
)	O
T3	O
-	O
15	O
mg/kg	O
and	O
3	O
)	O
vehicle	O
without	O
T3	O
(	O
T3	O
negative	O
)	O
for	O
8	O
weeks	O
.	O

Each	O
group	O
was	O
subdivided	O
into	O
three	O
intervention	O
arms	O
:	O
1	O
)	O
T3	O
-	O
4	O
mg/kg	O
,	O
2	O
)	O
T3	B:C0949647
-	O
15	O
mg/kg	O
and	O
3	O
)	O
vehicle	O
without	O
T3	O
(	O
T3	O
negative	O
)	O
for	O
8	O
weeks	O
.	O

Each	O
group	O
was	O
subdivided	O
into	O
three	O
intervention	O
arms	O
:	O
1	O
)	O
T3	O
-	O
4	O
mg/kg	O
,	O
2	O
)	O
T3	O
-	O
15	O
mg/kg	O
and	O
3	O
)	O
vehicle	B:C0324547
without	O
T3	O
(	O
T3	O
negative	O
)	O
for	O
8	O
weeks	O
.	O

Each	O
group	O
was	O
subdivided	O
into	O
three	O
intervention	O
arms	O
:	O
1	O
)	O
T3	O
-	O
4	O
mg/kg	O
,	O
2	O
)	O
T3	O
-	O
15	O
mg/kg	O
and	O
3	O
)	O
vehicle	O
without	O
T3	B:C0949647
(	O
T3	O
negative	O
)	O
for	O
8	O
weeks	O
.	O

Each	O
group	O
was	O
subdivided	O
into	O
three	O
intervention	O
arms	O
:	O
1	O
)	O
T3	O
-	O
4	O
mg/kg	O
,	O
2	O
)	O
T3	O
-	O
15	O
mg/kg	O
and	O
3	O
)	O
vehicle	O
without	O
T3	O
(	O
T3	B:C0949647
negative	O
)	O
for	O
8	O
weeks	O
.	O

Serial	O
fasting	B:C0015663
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	B:C0178913
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	B:C0430044
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	B:C0003483
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	B:C0040300
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	B:C0005516
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	B:C1155002
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	B:C0021368
and	O
plaque	O
stability	O
.	O

Serial	O
fasting	O
blood	O
samples	I:C0178913
were	O
obtained	O
for	O
lipid	O
profile	I:C0430044
,	O
and	O
whole	O
lengths	O
of	O
aorta	O
were	O
used	O
to	O
determine	O
tissue	O
markers	O
of	O
endothelial	O
activation	I:C1155002
,	O
inflammation	O
and	O
plaque	B:C0332461
stability	O
.	O

In	O
B1	O
,	O
atherosclerotic	B:C0004153
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	B:C0221198
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	B:C0949647
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	B:C0003483
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	B:C0040300
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	B:C1171362
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	B:C0078056
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	B:C0078056
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	B:C0968475
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	B:C0968475
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	B:C0949647
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	B:C0949647
-	O
negative	O
rabbits	O
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B1	O
,	O
atherosclerotic	O
lesion	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
was	O
significantly	O
reduced	O
(	O
p=0.008	O
)	O
,	O
while	O
aortic	O
tissue	O
expression	O
of	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
(	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
)	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
matrix	O
metalloproteinase	I:C0968475
(	O
MMP	O
-	I:C0968475
12	I:C0968475
)	O
was	O
reduced	O
in	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
compared	O
to	O
T3	O
-	O
negative	O
rabbits	B:C0324547
group	O
(	O
0.2±0.1	O
vs.	O
28.5±3.1	O
%	O
;	O
3.0±1.6	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
5.2±2.2	O
vs.	O
27.7±0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	B:C0949647
-	O
15	O
mg/kg	O
group	O
showed	O
reduction	O
in	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
and	O
MMP	O
-	I:C0968475
12	I:C0968475
(	O
3.9±1.9	O
vs.	O
28.5±3.1	O
%	O
;	O
10.3±0.5	O
vs.	O
59.8±8.5	O
%	O
;	O
2.6±1.7	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
16.2±3.2	O
vs.	O
27.7	O
0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduction	O
in	O
vascular	B:C0078056
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
and	O
MMP	O
-	I:C0968475
12	I:C0968475
(	O
3.9±1.9	O
vs.	O
28.5±3.1	O
%	O
;	O
10.3±0.5	O
vs.	O
59.8±8.5	O
%	O
;	O
2.6±1.7	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
16.2±3.2	O
vs.	O
27.7	O
0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduction	O
in	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
E-	B:C0115305
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
and	O
MMP	O
-	I:C0968475
12	I:C0968475
(	O
3.9±1.9	O
vs.	O
28.5±3.1	O
%	O
;	O
10.3±0.5	O
vs.	O
59.8±8.5	O
%	O
;	O
2.6±1.7	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
16.2±3.2	O
vs.	O
27.7	O
0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduction	O
in	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
and	O
MMP	O
-	I:C0968475
12	I:C0968475
(	O
3.9±1.9	O
vs.	O
28.5±3.1	O
%	O
;	O
10.3±0.5	O
vs.	O
59.8±8.5	O
%	O
;	O
2.6±1.7	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
16.2±3.2	O
vs.	O
27.7	O
0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduction	O
in	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
and	O
MMP	B:C0968475
-	I:C0968475
12	I:C0968475
(	O
3.9±1.9	O
vs.	O
28.5±3.1	O
%	O
;	O
10.3±0.5	O
vs.	O
59.8±8.5	O
%	O
;	O
2.6±1.7	O
vs.	O
14.0±1.7	O
%	O
;	O
and	O
16.2±3.2	O
vs.	O
27.7	O
0.8	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	B:C0949647
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	B:C0003483
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	B:C0040300
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	B:C1171362
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	B:C0063695
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	B:C0063695
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	B:C0115305
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	B:C0968475
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	B:C0165519
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	B:C0949647
-	O
negative	O
rabbits	O
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

In	O
B2	O
,	O
T3	O
-	O
4	O
mg	O
/	O
kg	O
group	O
reduced	O
aortic	O
tissue	O
expression	O
of	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
(	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
)	O
,	O
E-	O
selectin	I:C0115305
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
compared	O
to	O
T3	O
-	O
negative	O
rabbits	B:C0324547
group	O
(	O
29.9	O
±2.4	O
vs.	O
55.3±1.3	O
%	O
;	O
26.7±1.5	O
vs.	O
60.5±7.6	O
%	O
;	O
15.7±0.7	O
vs.	O
27.7±4.8	O
%	O
;	O
34.8±2.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
25.89±3.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
)	O
.	O

T3	B:C0949647
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	B:C0078056
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	B:C0063695
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	B:C0968475
-	I:C0968475
12	I:C0968475
and	O
MMP	O
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

T3	O
-	O
15	O
mg/kg	O
group	O
showed	O
reduced	O
vascular	O
cellular	I:C0078056
adhesion	I:C0078056
molecule	I:C0078056
1	I:C0078056
,	O
intercellular	O
adhesion	I:C0063695
molecule	I:C0063695
1	I:C0063695
,	O
E-	O
selectin	O
,	O
interleukin	O
-	I:C0021760
6	I:C0021760
,	O
MMP	O
-	I:C0968475
12	I:C0968475
and	O
MMP	B:C0165519
-	I:C0165519
9	I:C0165519
(	O
20.5±3.3	O
vs.	O
35.6±2.5	O
%	O
;	O
24.9±1.3	O
vs.	O
55.3±1.3	O
%	O
;	O
29.9±6.7	O
vs.	O
60.5±7.6	O
;	O
11.3±2.2	O
vs.	O
27.7±4.8	O
%	O
;	O
23.0±1.7	O
vs.	O
46.5±3.4	O
%	O
;	O
and	O
17.6±1.9	O
vs.	O
45.9±1.7	O
%	O
,	O
respectively	O
,	O
p<0.05	O
.	O

These	O
findings	B:C0243095
suggest	O
the	O
possible	O
atheroprotective	O
role	O
T3	O
plays	O
as	O
an	O
adjunct	O
supplementation	I:C0677850
to	O
standard	O
treatment	O
in	O
the	O
prevention	O
of	O
CAD	O
.	O

These	O
findings	O
suggest	O
the	O
possible	O
atheroprotective	O
role	O
T3	B:C0949647
plays	O
as	O
an	O
adjunct	O
supplementation	I:C0677850
to	O
standard	O
treatment	O
in	O
the	O
prevention	O
of	O
CAD	O
.	O

These	O
findings	O
suggest	O
the	O
possible	O
atheroprotective	O
role	O
T3	O
plays	O
as	O
an	O
adjunct	B:C0677850
supplementation	I:C0677850
to	O
standard	O
treatment	O
in	O
the	O
prevention	O
of	O
CAD	O
.	O

These	O
findings	O
suggest	O
the	O
possible	O
atheroprotective	O
role	O
T3	O
plays	O
as	O
an	O
adjunct	O
supplementation	I:C0677850
to	O
standard	O
treatment	B:C0087111
in	O
the	O
prevention	O
of	O
CAD	O
.	O

These	O
findings	O
suggest	O
the	O
possible	O
atheroprotective	O
role	O
T3	O
plays	O
as	O
an	O
adjunct	O
supplementation	I:C0677850
to	O
standard	O
treatment	O
in	O
the	O
prevention	O
of	O
CAD	B:C0010068
.	O

